Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) closed at $0.08 down -0.50% from its previous closing price of $0.08. In other words, the price has decreased by -$0.50 from its previous closing price. On the day, 82.87 million shares were traded.
Ratios:
For a deeper understanding of Adaptimmune Therapeutics Plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.79 and its Current Ratio is at 2.02.
On June 26, 2025, Mizuho Downgraded its rating to Neutral which previously was Outperform but kept the price unchanged to $0.50.
On July 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on July 30, 2024, with a $4 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 28 ’25 when EcoR1 Capital, LLC sold 33,931,740 shares for $0.11 per share. The transaction valued at 3,817,321 led to the insider holds 130,492,680 shares of the business.
EcoR1 Capital, LLC sold 27,433,338 shares of ADAP for $2,800,944 on Jul 30 ’25. The 10% Owner now owns 100,371,882 shares after completing the transaction at $0.10 per share. On Jul 29 ’25, another insider, EcoR1 Capital, LLC, who serves as the 10% Owner of the company, sold 2,687,460 shares for $0.10 each. As a result, the insider received 271,971 and left with 127,805,220 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 0.11.
Stock Price History:
Over the past 52 weeks, ADAP has reached a high of $1.36, while it has fallen to a 52-week low of $0.08. The 50-Day Moving Average of the stock is -68.27%, while the 200-Day Moving Average is calculated to be -82.55%.
Shares Statistics:
A total of 257.85M shares are outstanding, with a floating share count of 229.65M. Insiders hold about 10.94% of the company’s shares, while institutions hold 29.90% stake in the company.
